Cadence Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$11.1M Sell
10,349
-1,042
-9% -$996K 0.65% 31
2025
Q3
$8.69M Buy
11,391
+48
+0.4% +$35.7K 0.53% 42
2025
Q2
$8.84M Sell
11,343
-98
-0.9% -$76.2K 0.58% 37
2025
Q1
$9.45M Sell
11,441
-268
-2% -$223K 0.67% 31
2024
Q4
$9.04M Sell
11,709
-102
-0.9% -$84.5K 0.61% 35
2024
Q3
$10.5M Sell
11,811
-1,117
-9% -$1M 0.72% 30
2024
Q2
$11.7M Sell
12,928
-88
-0.7% -$70.4K 0.88% 23
2024
Q1
$10.1M Buy
13,016
+540
+4% +$384K 0.74% 29
2023
Q4
$7.27M Sell
12,476
-175
-1% -$102K 0.59% 37
2023
Q3
$6.8M Sell
12,651
-128
-1% -$66K 0.6% 39
2023
Q2
$5.99M Sell
12,779
-268
-2% -$112K 0.52% 46
2023
Q1
$4.48M Buy
13,047
+878
+7% +$296K 0.41% 60
2022
Q4
$4.45M Buy
12,169
+180
+2% +$63.8K 0.41% 59
2022
Q3
$3.88M Buy
11,989
+10,416
+662% +$3.3M 0.4% 64
2022
Q2
$510K Buy
1,573
+30
+2% +$9.01K 0.07% 129
2022
Q1
$442K Buy
1,543
+13
+0.8% +$3.35K 0.06% 142
2021
Q4
$423K Hold
1,530
0.05% 149
2021
Q3
$354K Hold
1,530
0.05% 159
2021
Q2
$351K Buy
1,530
+175
+13% +$35.2K 0.05% 161
2021
Q1
$253K Sell
1,355
-4
-0.3% -$782 0.04% 177
2020
Q4
$230K Hold
1,359
0.04% 199
2020
Q3
$201K Sell
1,359
-16
-1% -$2.48K 0.04% 175
2020
Q2
$226K Buy
+1,375
New +$211K 0.05% 172
2020
Q1
Sell
-1,675
Closed -$220K 197
2019
Q4
$220K Buy
+1,675
New +$194K 0.04% 182
2019
Q2
Sell
-1,923
Closed -$250K 230
2019
Q1
$250K Sell
1,923
-270
-12% -$32.8K 0.03% 203
2018
Q4
$254K Buy
2,193
+280
+15% +$31.3K 0.03% 197
2018
Q3
$206K Buy
+1,913
New +$191K 0.02% 240

Other funds holding LLY

Cadence Bank's LLY Position: Q4 2025 in Review

Cadence Bank reduced its Eli Lilly (LLY) stake by 9.1% in Q4 2025, selling an estimated $996K and leaving 10,349 shares worth $11.1M. The position accounts for 0.65% of the portfolio, ranked #31.

Cadence Bank first reported a position in LLY in Q3 2018 and has held it in 27 quarters since. The position peaked at $11.7M in Q2 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Cadence Bank held 10,349 shares of Eli Lilly worth $11.1M as of Q4 2025.
  • Cadence Bank sold 1,042 Eli Lilly shares in Q4 2025, an estimated $996K.
  • Eli Lilly made up 0.65% of Cadence Bank's portfolio in Q4 2025, its #31 holding.
  • Cadence Bank first reported a position in Eli Lilly in Q3 2018 and has held it in 27 quarters since.
  • Cadence Bank's Eli Lilly position peaked at $11.7M in Q2 2024.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.